20 results
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture
6-K
EX-10.1
qrv4smtcpz 9v617jb
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-1.1
szz2vb wi19sihlwcr
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
r39w4dmzcgrk
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
20-F/A
gbdum mqsap
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
EX-99.2
xis27be v30an5
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
vt4ta9dbsak utxkhxv
19 Nov 18
Agreement and Plan of Merger
4:34pm
424B5
x4o7478wtrdpfffz01e
18 Mar 16
Prospectus supplement for primary offering
12:00am
20-F
fymx1av15w3 bn19s
31 Mar 15
Annual report (foreign)
12:00am
424B4
7ex5l0
31 Jul 14
Prospectus supplement with pricing info
12:00am
F-1/A
u4a8hllet
8 Jul 14
Registration statement (foreign) (amended)
12:00am
- Prev
- 1
- Next